Abstract
Twelve surgically removed human kidneys (mainly tumor kidneys) were investigated. The investigations comprised perfusion criteria (perfusion flow, perfusion pressure, perfusion resistance, electrolyte equilibration). During perfusion of the kidneys with HTK solution, the perfusion resistance was nearly three times as high in human kidneys as in canine kidneys perfused under the same conditions in previous studies. Beside possible species differences the raised perfusion resistance may be explained by the greater trauma to the human kidneys due to the surgery, the primary ischemic stress which cannot be avoided clinically and the often nonoptimal initial diuresis. Nevertheless definitive perfusion is possible under clinical conditions although pronounced increases of perfusion resistance may occur. As indicated by the raised perfusion resistance of human kidneys under clinical conditions as compared with canine kidneys in an experimental model, electrolyte equilibration of human kidneys was protracted. For this reason, a duration of perfusion of at least 10 min is necessary in clinical application of HTK solution, i.e., longer than in animal experiments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Belzer FO, Reed TW, Pryor JP, Kountz SL, Dunphy JE (1970) Cause of renal injury in kidneys obtained from cadaver donors. Surg Gynecol Obstet 130: 467
Blech M (1988) In-situ-Protektion menschlicher Nieren zum Zwecke organerhaltender Operationen am blutleeren Organ. Med Habil Schr Göttingen, p 122
Blech M (1992) Nierenprotektion mit der HTK-Lösung. Perfusionsverhalten menschlicher Nieren und klinische Ergebnisse der in-situ-Protektion. In: Blech M, Isemer FE (eds) Nierenprotektion mit der HTK-Lösung. Wolfgang-Pabst-Verlag, Lengerich, p 7
Blech M, Kallerhoff M, Kehrer G, v.Romatowski HJ, Mündemann-Schultz C, Helmchen U, Truss F, Bretschneider HJ (1988) Klinische Anwendung der kardioplegischen Lösung HTK nach Bretschneider zur in-situ-Protektion der Niere. Urologe A 27: 44
Blech M, Kallerhoff M, Kehrer G, Ringert RH, Bretschneider HJ (1990) “Imperative Indikation” zur organerhaltenden Nierentumorchirurgie. Helv Chir Acta 57: 435
Bretschneider HJ (1964) Uberlebenszeit und Wiederbelebungszeit des Herzens bei Normo- und Hypothermie. Verh Dtsch Ges Kreislaufforsch 30: 11
Bretschneider HJ (1980) Myocardial protection. Thorac Cardiovasc Sung 28: 295
Bretschneider HJ, Gebhard MM, Preusse CJ (1981) Reviewing the pros and cons of myocardial preservation within cardiac surgery. In: Longmore ED (ed) Towards safer cardiac surgery. MTP Press, Lancaster, p 21
Götz L, Siebert G, Gröne HJ, Ringert RH, Schorn B, Schunck O, Zöller G, Kallerhoff M (1992) Organ preserving renal surgery in situ. Experimental and clinical results. In: Kirste G (ed) Custodiol Symposium Freiburg 1991. Innovations-VerlagsGesellschaft, Seeheim, p 21
Grupp G, Heimpel H (1958) Zum Problem der “reaktiven Hyperämie” der Niere. Pflügers Arch 267: 426
Hoyer J (1992) Comparison of three different preservation solutions: one center's experience. In: Kirste G (ed) Custodiol Symposium Freiburg 1991. Innovations-Verlags-Gesellschaft, Seeheim, p 39
Kallerhoff M (1986) Nierenprotektion in-situ in Anlehnung an das Verfahren zur Myokardprotektion nach Bretschneider im Vergleich zum Euro-Collins-Verfahren. Med Habil Schr Göttingen, p 35
Kallerhoff M, Kehrer G, Siekmann W, Blech M, Gebhard MM, Helmchen U, Bretschneider HJ (1985) Experimentelle Anwendung der kardioplegischen Losung HTK nach Bretschneider für eine in-situ-Protektion von Nieren. In: Harzmann R, Jacobi GH, Weissbach L (ed) Experimentelle Urologie. Springer, Berlin Heidelberg New York, p 180
Kallerhoff M, Blech M, Kehrer G, Kleinert H, Langheinrich M, Siekmann W, Helmchen U, Bretschneider HJ (1987) Shortterm perfusion and “equilibration” of canine kidneys with protective solutions. Urol Res 15: 5
Kallerhoff M, Blech M, Götz L, Kehrer G, Bretschneider HJ, Helmchen U, Ringert RH (1990) A new method for conservative renal surgery: experimental and first clinical results. Langenbecks Arch Chir 375: 340
Kehrer G, Gebhard MM, Kallerhoff M, Siekmann W, Blech M, Helmchen U, Bretschneider HJ (1984) The influence of glucose premedication on perfusion resistance, perfusional diuresis and equilibration of the dog kidney during perfusion with Bretschneider's cardioplegic solution “HTK” in standardized anaesthesia. Pflügers Arch 400 [Suppl]: R 22
Kehrer G, Blech M, Gebhard MM, Kallerhoff M, Siekmann W, Helmchen U, Bretschneider HJ (1985) Günstige Effekte einer Glucose-Prämedikation auf den anaeroben Energieumsatz der Hundeniere bei Protektion mit einer histidingepufferten Lösung im Vergleich zu einer OsmofundinPrämedikation. In: Harzmann R, Jacobi GH, Weissbach L (eds) Experimentelle Urologie. Springer, Berlin Heidelberg New York, p 172
Kehrer G, Blech M, Kallerhoff M, Kleinert H, Bretschneider HJ (1985) Influence of preischemic perfusion resistance on postischemic renal function. Pflügers Arch 405 [Suppl 2]: R 33
Kehrer G, Kallerhoff M, Probst R, Siekmann W, Blech M, Bretschneider HJ, Helmchen U (1985) Construction and experimental application of a catheter for selective arterial kidney perfusion in situ. Urol Res 13: 85
Rathert P, Lutzeyer W (1981) Untersuchungen zur extrakorporalen Nierenchirurgie, Nierenperfusion und Autotransplantation. Westdeutscher Verlag, Opladen, p 77
Voss R, Ruile K, Vogell W, Kunz W (1970) Untersuchungen zur Ischämietoleranz der Nieren. Klin Wochenschr 48: 1089
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blech, M., Hummel, G., Kallerhoflf, M. et al. Electrolyte equilibration of human kidneys during perfusion with HTK-solution according to Bretschneider. Urol. Res. 25, 331–335 (1997). https://doi.org/10.1007/BF01294660
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01294660